N-(2,5-dimethoxybenzyl)-3-[(2-oxo-1,3-benzoxazol-3(2H)-yl)methyl]-1,2,4-oxadiazole-5-carboxamide结构式
|
常用名 | N-(2,5-dimethoxybenzyl)-3-[(2-oxo-1,3-benzoxazol-3(2H)-yl)methyl]-1,2,4-oxadiazole-5-carboxamide | 英文名 | N-(2,5-dimethoxybenzyl)-3-[(2-oxo-1,3-benzoxazol-3(2H)-yl)methyl]-1,2,4-oxadiazole-5-carboxamide |
|---|---|---|---|---|
| CAS号 | 1111973-90-0 | 分子量 | 484.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C26H20N4O4S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(2,5-dimethoxybenzyl)-3-[(2-oxo-1,3-benzoxazol-3(2H)-yl)methyl]-1,2,4-oxadiazole-5-carboxamide |
|---|
| 分子式 | C26H20N4O4S |
|---|---|
| 分子量 | 484.5 |
| InChIKey | WIZQBILSGORMQU-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC=C1)C2=NOC(=N2)CSC3=NC4=CC5=C(C=C4C(=O)N3CC6=CC=CC=C6)OCO5 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|